Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Treatment
243 results:

  • 1. The combination of il-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.
    Wang D; Wang X; Zhang Y; Yu L; An J; Wang X; Huang Y; Han X
    Front Immunol; 2024; 15():1309509. PubMed ID: 38352877
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
    Amaria R; Knisely A; Vining D; Kopetz S; Overman MJ; Javle M; Antonoff MB; Tzeng CD; Wolff RA; Pant S; Lito K; Rangel K; Fellman B; Yuan Y; Lu KH; Sakellariou-Thompson D; Haymaker CL; Forget MA; Hwu P; Bernatchez C; Jazaeri AA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309721
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
    Li CMY; Tomita Y; Dhakal B; Tin T; Li R; Wright JA; Vrbanac L; Woods SL; Drew P; Price T; Smith E; Maddern GJ; Fenix K
    Cancer Immunol Immunother; 2024 Jan; 73(1):6. PubMed ID: 38231291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.
    Mahdi HS; Woodall-Jappe M; Singh P; Czuczman MS
    Front Immunol; 2023; 14():1268979. PubMed ID: 38022532
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Reigniting hope in cancer treatment: the promise and pitfalls of il-2 and il-2R targeting strategies.
    Muhammad S; Fan T; Hai Y; Gao Y; He J
    Mol Cancer; 2023 Jul; 22(1):121. PubMed ID: 37516849
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytokine concentration in peripheral blood of patients with colorectal cancer.
    Li W; Chen F; Gao H; Xu Z; Zhou Y; Wang S; Lv Z; Zhang Y; Xu Z; Huo J; Zhao J; Zong Y; Feng W; Shen X; Wu Z; Lu A
    Front Immunol; 2023; 14():1175513. PubMed ID: 37063892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical cancer Cells.
    Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
    Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
    Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
    Chen MC; Lai KS; Chien KL; Teng ST; Lin YR; Chao W; Lee MJ; Wei PL; Huang YH; Kuo HP; Weng CM; Chou CL
    Front Immunol; 2022; 13():871828. PubMed ID: 35585988
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer.
    Zhou J; Xu Y; Wang G; Mei T; Yang H; Liu Y
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35552764
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with colorectal cancer Undergoing Chemotherapy: A Randomized Controlled Trial.
    Panahi Y; Saberi-Karimian M; Valizadeh O; Behnam B; Saadat A; Jamialahmadi T; Majeed M; Sahebkar A
    Adv Exp Med Biol; 2021; 1328():1-9. PubMed ID: 34981467
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Engineering NK-92 Cell by Upregulating CXCR2 and il-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon cancer.
    Gao L; Yang L; Zhang S; Ge Z; Su M; Shi Y; Wang X; Huang C
    J Interferon Cytokine Res; 2021 Dec; 41(12):450-460. PubMed ID: 34935484
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bioinformatics and
    Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
    Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects.
    Suarez-Carmona M; Williams A; Schreiber J; Hohmann N; Pruefer U; Krauss J; Jäger D; Frömming A; Beyer D; Eulberg D; Jungelius JU; Baumann M; Mangasarian A; Halama N
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607895
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
    Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
    Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]    [Full Text] [Related]  

  • 17. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
    Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
    Front Immunol; 2021; 12():619932. PubMed ID: 33868236
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gossypol decreased cell viability and down-regulated the expression of a number of genes in human colon cancer cells.
    Cao H; Sethumadhavan K; Cao F; Wang TTY
    Sci Rep; 2021 Mar; 11(1):5922. PubMed ID: 33723275
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TIGIT promotes CD8
    Liang R; Zhu X; Lan T; Ding D; Zheng Z; Chen T; Huang Y; Liu J; Yang X; Shao J; Wei H; Wei B
    Cancer Immunol Immunother; 2021 Oct; 70(10):2781-2793. PubMed ID: 33634371
    [TBL] [Abstract] [Full Text] [Related]  


    of 13.